276 related articles for article (PubMed ID: 16330568)
1. Past, present, and future of annexin A5: from protein discovery to clinical applications.
Boersma HH; Kietselaer BL; Stolk LM; Bennaghmouch A; Hofstra L; Narula J; Heidendal GA; Reutelingsperger CP
J Nucl Med; 2005 Dec; 46(12):2035-50. PubMed ID: 16330568
[TBL] [Abstract][Full Text] [Related]
2. Comparison between human pharmacokinetics and imaging properties of two conjugation methods for 99mTc-annexin A5.
Boersma HH; Liem IH; Kemerink GJ; Thimister PW; Hofstra L; Stolk LM; van Heerde WL; Pakbiers MT; Janssen D; Beysens AJ; Reutelingsperger CP; Heidendal GA
Br J Radiol; 2003 Aug; 76(908):553-60. PubMed ID: 12893698
[TBL] [Abstract][Full Text] [Related]
3. Visualization of cell death in vivo with the annexin A5 imaging protocol.
Reutelingsperger CP; Dumont E; Thimister PW; van Genderen H; Kenis H; van de Eijnde S; Heidendal G; Hofstra L
J Immunol Methods; 2002 Jul; 265(1-2):123-32. PubMed ID: 12072183
[TBL] [Abstract][Full Text] [Related]
4. XTEN-annexin A5: XTEN allows complete expression of long-circulating protein-based imaging probes as recombinant alternative to PEGylation.
Haeckel A; Appler F; Figge L; Kratz H; Lukas M; Michel R; Schnorr J; Zille M; Hamm B; Schellenberger E
J Nucl Med; 2014 Mar; 55(3):508-14. PubMed ID: 24549285
[TBL] [Abstract][Full Text] [Related]
5. Site-specifically 11C-labeled Sel-tagged annexin A5 and a size-matched control for dynamic in vivo PET imaging of protein distribution in tissues prior to and after induced cell death.
Cheng Q; Lu L; Grafström J; Olofsson MH; Thorell JO; Samén E; Johansson K; Ahlzén HS; Linder S; Arnér ES; Stone-Elander S
Biochim Biophys Acta; 2013 Mar; 1830(3):2562-73. PubMed ID: 23262140
[TBL] [Abstract][Full Text] [Related]
6. Domain IV of Annexin A5 Is Critical for Binding Calcium and Guarantees Its Maximum Binding to the Phosphatidylserine Membrane.
Wang J; Liu J; Cao Y; Hu M; Hua Z
Molecules; 2017 Dec; 22(12):. PubMed ID: 29257055
[No Abstract] [Full Text] [Related]
7. Annexin A5: an imaging biomarker of cardiovascular risk.
Laufer EM; Reutelingsperger CP; Narula J; Hofstra L
Basic Res Cardiol; 2008 Mar; 103(2):95-104. PubMed ID: 18324365
[TBL] [Abstract][Full Text] [Related]
8. In vivo detection of cell death in the area at risk in acute myocardial infarction.
Thimister PW; Hofstra L; Liem IH; Boersma HH; Kemerink G; Reutelingsperger CP; Heidendal GA
J Nucl Med; 2003 Mar; 44(3):391-6. PubMed ID: 12621005
[TBL] [Abstract][Full Text] [Related]
9. The role of labeled Annexin A5 in imaging of programmed cell death. From animal to clinical imaging.
Kietselaer BL; Hofstra L; Dumont EA; Reutelingsperger CP; Heidendal GA
Q J Nucl Med; 2003 Dec; 47(4):349-61. PubMed ID: 14973424
[TBL] [Abstract][Full Text] [Related]
10. Long-circulating XTEN864-annexin A5 fusion protein for phosphatidylserine-related therapeutic applications.
Haeckel A; Ascher L; Beindorff N; Prasad S; Garczyńska K; Guo J; Schellenberger E
Apoptosis; 2021 Oct; 26(9-10):534-547. PubMed ID: 34405304
[TBL] [Abstract][Full Text] [Related]
11. A dual-labeled Annexin A5 is not suited for SPECT imaging of brain cell death in experimental murine stroke.
Zille M; Harhausen D; De Saint-Hubert M; Michel R; Reutelingsperger CP; Dirnagl U; Wunder A
J Cereb Blood Flow Metab; 2014 Sep; 34(9):1568-70. PubMed ID: 24984896
[TBL] [Abstract][Full Text] [Related]
12. Targeting phosphatidylserine for radionuclide-based molecular imaging of apoptosis.
Wuest M; Perreault A; Richter S; Knight JC; Wuest F
Apoptosis; 2019 Apr; 24(3-4):221-244. PubMed ID: 30684144
[TBL] [Abstract][Full Text] [Related]
13. In vitro and in vivo comparison of 18F and 123I-labeled ML10 with 68Ga-Cys2-AnxA5 for molecular imaging of apoptosis.
Bauwens M; De Saint-Hubert M; Cleynhens J; Vandeputte C; Li J; Devos E
Q J Nucl Med Mol Imaging; 2013 Jun; 57(2):187-200. PubMed ID: 23389693
[TBL] [Abstract][Full Text] [Related]
14. Site-specific 68Ga-labeled Annexin A5 as a PET imaging agent for apoptosis.
Bauwens M; De Saint-Hubert M; Devos E; Deckers N; Reutelingsperger C; Mortelmans L; Himmelreich U; Mottaghy FM; Verbruggen A
Nucl Med Biol; 2011 Apr; 38(3):381-92. PubMed ID: 21492787
[TBL] [Abstract][Full Text] [Related]
15. Bending of a lipid membrane edge by annexin A5 trimers.
Pandey MP; Telles de Souza PC; Pezeshkian W; Khandelia H
Biophys J; 2024 Apr; 123(8):1006-1014. PubMed ID: 38486451
[TBL] [Abstract][Full Text] [Related]
16. Engineered annexin A5 variants have impaired cell entry for molecular imaging of apoptosis using pretargeting strategies.
Ungethüm L; Kenis H; Nicolaes GA; Autin L; Stoilova-McPhie S; Reutelingsperger CP
J Biol Chem; 2011 Jan; 286(3):1903-10. PubMed ID: 21078669
[TBL] [Abstract][Full Text] [Related]
17. Molecular imaging of apoptosis with radio-labeled Annexin A5 focused on the evaluation of tumor response to chemotherapy.
Kuge Y; Zhao S; Takei T; Tamaki N
Anticancer Agents Med Chem; 2009 Nov; 9(9):1003-11. PubMed ID: 19663783
[TBL] [Abstract][Full Text] [Related]
18. Counting heads in the war against cancer: defining the role of annexin A5 imaging in cancer treatment and surveillance.
Corsten MF; Hofstra L; Narula J; Reutelingsperger CP
Cancer Res; 2006 Feb; 66(3):1255-60. PubMed ID: 16452175
[TBL] [Abstract][Full Text] [Related]
19. Annexin A5 as a potential marker in tumors.
Peng B; Guo C; Guan H; Liu S; Sun MZ
Clin Chim Acta; 2014 Jan; 427():42-8. PubMed ID: 24121031
[TBL] [Abstract][Full Text] [Related]
20. 99mTc-labeled annexin V fragments: a potential SPECT radiopharmaceutical for imaging cell death.
Mukherjee A; Kothari K; Tóth G; Szemenyei E; Sarma HD; Környei J; Venkatesh M
Nucl Med Biol; 2006 Jul; 33(5):635-43. PubMed ID: 16843838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
